Denali Therapeutics Inc
0 analysts rank DNLI stock as an Overweight
Samantha Gray
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
Keeping an Eye on Denali Therapeutics Inc (DNLI) After Insider Trading Activity
Daniel Torres
Denali Therapeutics Inc’s recent filing unveils that its Officer CAROLE HO acquired Company’s shares for reported $35758.0 on Dec 04 ...
DNLI short interest declines, indicating growing optimism among investors
Daniel Torres
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
Analysts: DNLI stock price target of 33.5 in 12 months
Roman Campbell
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
